All
Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel
Boyd P, Fetherston SM, McCoy CF, Major I, Murphy DJ, Kumar S, Holt J, Brimer A, Blanda W, Devlin B, Malcolm RK. International Journal of Pharmaceutics. 511, no. 1 (10 Sept 2016): 619-629. More »
Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial
Dezzutti CS, Richardson-Harman N, Rohan L, Marzinke MA, Hoesley CJ, Panther L, Johnson S, Nuttall JP, Nel A, Chen BA. Medicine 95, no. 8 (2016 Jul): e4174. doi: 10.1097/MD.0000000000004174. More »
Development of a multi-layered vaginal tablet containing dapivirine, levonorgestrel and acyclovir for use as a multipurpose prevention technology
McConville C, Major I, Devlin B, Brimer A. European Journal of Pharmaceutics and Biopharmaceutics. 104 (Jul 2016): 171-9. More »
Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence
Spence P, Nel A, van Niekerk N, Derrick T, Wilder S, Devlin B. Journal of Pharmaceutical and Biomedical Analysis. 125 (5 Jun 2016): 94-100. More »
New Technologies for Women's HIV Prevention: The Payoff for Sustainable Development
New technologies for women that prevent HIV and unintended pregnancy could have an enormous payoff for sustainable development: a future free of AIDS, where women and girls thrive, and their... More »